More than 2 million people in the U.S. with an opioid use disorder (OUD) need treatment and an increasing number of individuals are receiving treatment, yet less than 20% receive effective medications such as buprenorphine. There are myriad reasons why individuals encounter barriers to receiving medication treatment but telehealth for OUD in the home is a new treatment model that may help address these issues. In this report from the Journal of the American Medical Association, the authors look at what is contributing to the emergence of this new service, the structure of care and how recent federal legislation and COVID-19 may accelerate growth.

Read more: